Showing 742 results
-
Ad hoc release /The U.S. Food and Drug Administration (FDA) has not raised any concerns related to the efficacy or safety of inclisiran. The complete response letter is due to unresolved facility inspection-related…
-
Press release /Dr. Boumediene Soufi, global head of Sandoz AMR (antimicrobial resistance) program, to represent Sandoz as Board member of AMR Industry Alliance (AMRIA)The Alliance brings together about 100 life…
-
Story /In Cameroon, seeking treatment for chronic diseases can be a long journey.
-
Featured News /
-
Story /Ice hockey used to help Tyler Patron combat cystic fibrosis, but he hopes the lab could yield stronger medicine.
-
Story /Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.
-
Featured News /
-
Press release /Updated segment financials reflect transfer of Ophthalmic Pharmaceuticals franchise from Alcon to Pharmaceuticals, and 19 mature products from Pharmaceuticals to Sandoz, as outlined in Q4 and FY…
-
In The News /In Forbes commentary, Novartis CEO says industry should focus on outcomes for patients and healthcare systems.